Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

NGS Data Repurposing Allows Detection of Gastric Cancer Biomarkers in Patient-Derived Extracellular Vesicles

Version 1 : Received: 15 March 2023 / Approved: 15 March 2023 / Online: 15 March 2023 (09:18:23 CET)

A peer-reviewed article of this Preprint also exists.

Maqueda, J.J.; Santos, M.; Ferreira, M.; Marinho, S.; Rocha, S.; Rocha, M.; Saraiva, N.; Bonito, N.; Carvalho, J.; Oliveira, C. NGS Data Repurposing Allows Detection of tRNA Fragments as Gastric Cancer Biomarkers in Patient-Derived Extracellular Vesicles. Int. J. Mol. Sci. 2023, 24, 8961. Maqueda, J.J.; Santos, M.; Ferreira, M.; Marinho, S.; Rocha, S.; Rocha, M.; Saraiva, N.; Bonito, N.; Carvalho, J.; Oliveira, C. NGS Data Repurposing Allows Detection of tRNA Fragments as Gastric Cancer Biomarkers in Patient-Derived Extracellular Vesicles. Int. J. Mol. Sci. 2023, 24, 8961.

Abstract

Transfer RNA fragments (tRFs) have gene silencing effects similarly to miRNAs, can be sorted into extracellular vesicles (EVs) and are emerging as potential circulating biomarkers for cancer diagnosis. We aimed at analyzing the expression of tRFs in gastric cancer (GC) and understanding their potential as biomarkers. We explored miRNA datasets from gastric tumors and normal adjacent tissues (NAT) from TCGA repository, and proprietary 3D-cultured GC cell lines and corresponding EVs, in order to identify differentially represented tRFs using MINTmap and R/Bioconductor packages. Selected tRFs were validated in patient-derived EVs. We found 613 Differentially Expressed (DE)-tRFs in the TCGA dataset, of which 19 were concomitantly upregulated in TCGA gastric tumors and present in 3D-cells and EVs, but barely expressed in NAT. Moreover, 20 tRFs were expressed in 3D-cells and EVs and downregulated in TCGA gastric tumors. Of these 39 DE-tRFs, 9 tRFs were also detected in patient-derived EVs. Interestingly, the targets of these 9 tRFs affect neutrophil activation and degranulation, cadherin binding, focal adhesion and cell-substrate junction, highlighting these pathways as major targets of EV-mediated crosstalk with the tumor microenvironment. Furthermore, as they are present in four distinct GC datasets and can be detected even in low quality patient-EV derived samples, they hold promise as GC biomarkers. By repurposing already available NGS data, we could identify and cross-validate a set of tRFs holding potential as GC diagnosis biomarkers.

Keywords

tRNA fragments; extracellular vesicles; Gastric Cancer; NGS data repurposing; cancer biomarkers

Subject

Biology and Life Sciences, Biochemistry and Molecular Biology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.